This funding opportunity supports research projects aimed at developing new animal drugs intended for minor uses in major species or for use in minor species. Grants assist in defraying costs of qualified safety and effectiveness testing required for FDA approval. Applicants must have an Investigational New Animal Drug file and a minor use or minor species designation from FDA/CVM, with study protocols reviewed by FDA/CVM's Office of New Animal Drug Evaluation.
Eligible applicants include entities developing veterinary drugs or their research partners who have an Investigational New Animal Drug file and a minor use or minor species designation from FDA/CVM. Various organization types including nonprofits, for-profits, governments, and educational instituti
